GENE ONLINE|News &
Opinion
Blog

Emicizumab
Pfizer, Sangamo Dose First Hemophilia A Patient in Phase 3 with Gene Therapy Candidate
2020-10-08
Sangamo’s Shares Goes up after the Announcement of Investigational Hemophilia A Gene Therapy Results
2019-07-19
Emicizumab promises weekly/biweekly prophylaxis in hemophilia-A patients
2018-09-04
LATEST
Study Finds Treatment Variations in Immunobullous Disorders Linked to Demographic Factors
2026-01-24
Study Finds Orexin Receptor Agonists May Pose Higher Fracture Risk Compared to Melatonin Receptor Agonists
2026-01-24
Researchers Develop Distributed Method Using Control Barrier Functions to Enhance Network Connectivity
2026-01-24
Study by Khamsai et al. Links Community Living Factors to Dementia Risk in Older Adults
2026-01-24
Researchers Use CFD Simulations to Optimize Ejector Design for Improved Hydrogen Recirculation in PEM Fuel Cells
2026-01-24
Researchers Develop Pre-Trained Models to Enhance Robotic Navigation in Complex Terrains
2026-01-24
3D Printing Technology Enhances Patient Education Through Physical Models in Healthcare
2026-01-24
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top